Inventor · disambiguated record
Yann Ratinaud
Also filed as: RATINAUD YANN
3 granted patents·16 pending applications·0 citations·filing 2018–2023
44Inventor score
Files withNESTLE SA19
Top patents by PatentIndex Score
19 records- 0161US2023095374A1Meroterpenoid compounds for use in the prevention and treatment of a neurological disorderNESTLE SA·Filed 2022·Application pending·0 cites
- 0255US2023002303A1Polyketide compound and derivatives thereof for use in the prevention and treatment of a neurological disorderNESTLE SA·Filed 2022·Application pending·0 cites
- 0352US2025345348A1Ampk activator (cbda) and sglt2 inhibitor for metabolic healthNESTLE SA·Filed 2023·Application pending·0 cites
- 0450US11339111B2Polyketide compound and derivatives thereof for use in the prevention and treatment of a neurological disorderNESTLE SA·Filed 2018·Granted May 24, 2022·0 cites·3 claims
- 0548US11510890B2Meroterpenoid compounds for use in the prevention and treatment of a neurological disorderNESTLE SA·Filed 2018·Granted Nov 29, 2022·0 cites·9 claims
- 0647US2022031636A1Compounds that enhance the action of metforminNESTLE SA·Filed 2019·Application pending·0 cites
- 0747US2023026772A1Dibenzopyran ampk activator compounds, compositions, methods and uses thereofNESTLE SA·Filed 2020·Application pending·0 cites
- 0847US2024010589A1Substituted resorcinol compounds as ampk activators, compositions, methods and uses thereofNESTLE SA·Filed 2021·Application pending·0 cites
- 0947US2023008317A1Z-stilbene ampk activator compounds, compositions, methods and uses thereofNESTLE SA·Filed 2020·Application pending·0 cites
- 1047US2022175713A1Depside trimeric compounds for skeletal muscle modulationNESTLE SA·Filed 2020·Application pending·0 cites
- 1147US2023035592A1Direct ampk activator compounds combined with indirect ampk activator compounds, compositions, methods and uses thereofNESTLE SA·Filed 2020·Application pending·0 cites
- 1247US2023048350A1Benzocoumarin ampk activator compounds, compositions, methods and uses thereofNESTLE SA·Filed 2020·Application pending·0 cites
- 1345US2022054448A1Novel polymethoxyflavone compounds for skeletal muscle modulation, methods and uses thereofNESTLE SA·Filed 2019·Application pending·0 cites
- 1445US2022041603A1Src inhibitor compounds for skeletal muscle modulation, methods and uses thereofNESTLE SA·Filed 2019·Application pending·0 cites
- 1545US2022062199A1Phenanthrene ampk activator compounds, compositions, methods and uses thereofNESTLE SA·Filed 2020·Application pending·0 cites
- 1644US11583507B2Direct AMPK activator compoundsNESTLE SA·Filed 2019·Granted Feb 21, 2023·0 cites·18 claims
- 1744US2023414638A1Substituted resorcylic acid compounds as ampk activator and uses thereofNESTLE SA·Filed 2021·Application pending·0 cites
- 1843US2022047552A1Raf-1 kinase inhibitor compounds for skeletal muscle modulation, methods and uses thereofNESTLE SA·Filed 2019·Application pending·0 cites
- 1941US2022184025A1Novel depside dimeric compounds for skeletal muscle modulation, methods and uses thereofNESTLE SA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yann Ratinaud files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →